Retinal Nerve Fiber Layer Thickness in Glaucoma Patients Treated with Multiple Intravitreal Anti-Vegf (Bevacizumab) Injections

Over the past decade, intravitreal injections of anti-VEGF agents have been widely used and intensively developed as a treatment option for many ophthalmological indications. Due to its availability and low cost, the most frequently used anti-VEGF agent is bevacizumab. This type of therapy is often...

Full description

Bibliographic Details

Published in:	Acta Clinica Croatica
Main Authors:	Andrijana Kopić, Dubravka Biuk, Josip Barać, Maja Vinković, Tvrtka Benašić, Vlatko Kopić
Format:	Article
Language:	English
Published:	Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2017-01-01
Subjects:	Vascular endothelial growth factor A Bevacizumab Retinal degeneration Macular edema Diabetes mellitus Glaucoma, primary open angle
Online Access:	https://hrcak.srce.hr/file/282145